TERNS INC has a total of 29 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Taiwan. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are KUDUK SCOTT D, GUANGZHOU INNOCARE PHARMA TECH CO LTD and SYNTEX LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | United States | 6 | |
#3 | Taiwan | 5 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Argentina | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Kirschberg Thorsten A | 23 |
#2 | Romero F Anthony | 23 |
#3 | Xu Yingzi | 23 |
#4 | Halcomb Randall | 22 |
#5 | Li Ben | 5 |
#6 | Yu Shanghai | 4 |
#7 | Zhong Weidong | 1 |
#8 | Fenaux Martijn | 1 |
#9 | Yu Shang-Hai | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021050945A1 | Thyroid hormone receptor beta agonist compounds | |
WO2021041237A1 | Thyroid hormone receptor beta agonist compounds | |
WO2020257527A1 | Compounds for inhibiting fgfr4 | |
WO2020227132A1 | Compounds for treating cancer | |
TW202027748A | Thyroid hormone receptor beta agonist compounds | |
CA3110576A1 | Compounds for treating certain leukemias | |
WO2020041741A1 | Thyroid hormone receptor beta agonist compounds | |
EP3773577A1 | Tricyclic ask1 inhibitors | |
CN111320609A | THR β receptor agonist compound and preparation method and application thereof |